China Resources Pharmaceutical Group Seeks to Sell 17.87% Stake in Tianmai Biotechnology
I'm PortAI, I can summarize articles.
China Resources Pharmaceutical Group Ltd. is looking to sell a 17.87% stake in Hefei Tianmai Biotechnology Development Co., Ltd. through a public tender on the Shanghai United Assets and Equity Exchange. The minimum listing price is approximately RMB 1.42 billion. As of now, no buyer has been identified, and the process will end if a suitable transferee is not found.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments